Aerogen

With technology deployed in more than 80 countries and used to treat over 30 million patients, Aerogen has established itself as the global leader in acute care aerosol drug delivery. Founded in Galway, Ireland, the company built its reputation on a single, well-defined mission: ensuring that critically ill patients receive inhaled medication reliably, precisely, and without disrupting the ventilation or oxygenation they depend on.

Vibrating Mesh Nebuliser Platform

The company's core technology is the vibrating mesh nebuliser, a platform protected by more than 300 international patents and referenced in over 300 clinical publications. At the heart of the system is a mesh containing thousands of precision-formed apertures that act as a micropump, converting liquid medication into a fine, low-velocity aerosol optimised for deep lung deposition. The Aerogen Solo, the flagship single-patient-use device, is integrated into ventilator platforms from GE Healthcare, Draeger, Philips, Covidien, and virtually every major manufacturer of critical care ventilators, making it the de facto standard across intensive care units worldwide.

One System Across the Respiratory Journey

A defining feature of the Aerogen portfolio is its continuity of care design. A single Aerogen Solo device supports patients across every stage of their hospital respiratory journey, from invasive mechanical ventilation in the ICU through non-invasive ventilation, high-flow nasal cannula therapy, and self-ventilating recovery, without the need to change hardware or recalibrate dosing. The Aerogen Ultra extends this flexibility by providing a handheld option for ambulatory or step-down settings. The continuous nebulisation tube set rounds out the range, enabling extended, precisely controlled drug administration where sustained dosing is clinically indicated.

Aerogen operates internationally, with facilities in Galway, Ireland, and commercial presence across North America, Europe, and Asia-Pacific. The company supports a broad formulary of inhaled agents, including bronchodilators, corticosteroids, mucolytics, and antimicrobials, reflecting the breadth of pharmacological need in acute respiratory care.

Further information is available at aerogen.com.